择期剖宫产妇女院内COVID-19感染的前瞻性队列研究
这项非随机前瞻性队列研究在纽约州两大学术机构评估择期剖宫产妇女的院内COVID-19感染率,术前SARS-CoV-2 PCR和IgG抗体均阴性的96例患者于出院后6-9天复测,无1例术前PCR阴性者术后转为阳性,提示严格围术期和产后方案可限制院内感染。
要点
- 择期剖宫产术前PCR阴性者术后6-9天复测无转阳。
- 96例完成术前术后检测,院内感染率 proxy 为0。
- 严格围术期和产后方案或可限制院内COVID-19感染。
核心结论
- 在严格围术期和产后方案下,择期剖宫产妇女的院内COVID-19感染可被限制。
研究设计与样本
- 非随机前瞻性队列研究,在纽约州两家大容量产房开展,评估择期剖宫产患者。
- 136例筛查,111例同意,96例完成术前和术后检测。
- 术前SARS-CoV-2 RT-PCR和IgG抗体阴性者于出院后6-9天复测。
主要发现
- 术前PCR阴性者术后无1例PCR阳性。
- 术前筛查中2例COVID-19阳性,25例拒绝参与。
关键数值与推荐
- 主要目标为COVID-19检测转换率,定义为术前阴性而出院后SARS-CoV-2 PCR阳性,作为院内感染率的代理指标。
临床怎么用
- 择期剖宫产可参考严格围术期和产后感染防控方案以降低院内COVID-19传播风险。
局限性
- 非随机设计,样本量有限,仅两家机构,结果需谨慎外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic placed obstetricians in a difficult position of continuing to perform elective cesarean delivery without the knowledge of the risk of the spread of nosocomial infection of the COVID-19 virus. OBJECTIVE: This study aimed to determine the nosocomial infection rate in women undergoing elective cesarean delivery at 2 academic institutions. STUDY DESIGN: This nonrandomized prospective cohort trial evaluated patients undergoing elective cesarean delivery during the reopening phase of the COVID-19 pandemic in the state of New York at 2 large volume labor and delivery units. Eligible patients with a negative preoperative reverse transcriptase-polymerase chain reaction test and immunoglobulin G antibody test for COVID-19 were retested 6 to 9 days after discharge. The primary objective was the COVID-19 test conversion rate defined as a positive polymerase chain reaction test for SARS-CoV-2 after discharge with a negative preoperative test. This was used as a proxy for the nosocomial infection rate. RESULTS: A total of 136 patients were screened for participation. Of these patients, 2 tested positive for COVID-19 on preoperative testing, and 25 declined to participate. Overall, 111 patients consented to participate, and 96 patients underwent both preoperative and postoperative testing. No patient with a negative polymerase chain reaction test preoperatively, had a positive polymerase chain reaction test for the COVID-19 virus postoperatively. CONCLUSION: With strict and methodical perioperative and postpartum protocols, we can limit nosocomial COVID-19 infection in women undergoing elective cesarean delivery.
引用
- Nizam A, Nimaroff ML, Menzin AW, et al. Nosocomial COVID-19 infection in women undergoing elective cesarean delivery: a prospective cohort study. Am J Obstet Gynecol MFM. 2021. PMID: 34543753. doi:10.1016/j.ajogmf.2021.100490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。